chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he is coughing; sneezing; This is a spontaneous report from a contactable consumer or other non hcp (patient's mother) from a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The reporter stated that the patient received the first dose of vaccine and after that he was tested negative for Covid-19, but on an unspecified date he was coughing and sneezing. The reporter also mentioned that the patient was scheduled to receive the second dose of vaccine on tomorrow (unspecified date) and wanted to know if it is okay for him to receive the vaccine as scheduled or if they need to re-schedule it. The patient underwent lab tests and procedures which included Covid-19 test which was negative on an unspecified date. Reporter declined to provide further contact information or verify her contact information as she was short on time. The outcome of the event was unknown.
Felt like crap the day; Initial information received on 02-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves an unknown age and gender patient who reported felt like crap the day (feeling abnormal) after receiving INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious felt like crap the day (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Felt like crap the day after but alot better today."  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome reported as unknown for the event.
devel t101 & diarrhea eve of vax; vomited x 1 on 27MAY; sleeping more than usual but wakens readily;
Pt developed a lot of soreness and swelling at injection site a few days after. She states it has decr but there is still a nodule (golf ball sized) at injection site over 3 weeks after.
On the the 16th of January I started feeling like a had a virus. The next day I started to cough and shortness of breath and was feeling like I was going to pass out. I also had diarrhea and lactic acidosis.
Rash, sensation of throat tightness/difficulty breathing, fever. Rec'd BENADRYL, hydroxyzine, prednisone, IV fluids, topical steroids.
Sleeplessness. Unable to stay asleep for more than 2 hours at a time since receiving first dose of the pfizer covid vaccine.
Expired Bexsero administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number AZX3Y, expiry date 28-FEB-2023) for prophylaxis.  On 14-MAR-2023, the patient received the 1st dose of Bexsero. On 14-MAR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Expired Bexsero administered). The outcome of the expired vaccine used was unknown.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK receipt date: 20-MAR-2023 The reporter was a Certified Medical Assistant. The vaccine administration facility was the same as primary reporter. Lot number provided by Healthcare Professional (HCP) did not pull up as a GlaxoSmithKline (GSK)vaccine. It was repeated and confirmed with HCP. The reporter had consented to follow-up via postal. The patient had received a dose of expired Bexsero vaccine, which had led to expired vaccine used.
Caller did not get swollen lymph nodes with 5th dose like caller did with the prior 4 doses.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), on 12May2022 as dose 4 (booster), single (Lot number: FM9992) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1:, Date: 22Dec2020, NDC number, lot number, expiration date: Just has lot number, EJ1685.), administration date: 22Dec2020, when the patient was 59-year-old, for COVID-19 immunization, reaction(s): "Nausea", "Fatigue", "muscle aches", "chills", "transient SOB", "runny nose", "weird headaches or fullness", "weird headaches or fullness", "Insomnia", "Light headness", "total body aches"; BNT162b2 (Dose 2:, Date: 12Jan2021, NDC number, lot number, expiration date: EK4176), administration date: 12Jan2021, when the patient was 59-year-old, for COVID-19 immunization, reaction(s): "Diarrhea", "swollen kness", "headaches", "Nausea", "Fatigue", "Chills", "Muscle aches", "Runny nose", "Sneezing", "Caller did not get swollen lymph nodes with 5th dose like caller did with the prior 4 doses"; BNT162b2 (Dose 3:, Date: 10Oct2021, NDC number, lot number, expiration date: Assuming FH8020, would be nice if stickers were put on vaccination card instead of handwriting on vaccination card.), administration date: 10Oct2021, when the patient was 59-year-old, for COVID-19 immunization, reaction(s): "Caller did not get swollen lymph nodes with 5th dose like caller did with the prior 4 doses.". The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Caller did not get swollen lymph nodes with 5th dose like caller did with the prior 4 doses.".; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201401432 similar report from same reporter;
esp. painful administration 1 day (expected) flu-like symptoms (similar to shot#1) and total exhaustion 5 days of  2-3 inch hot, red, hard, iching injection site (NEVER experienced this before with ANY shot) Today, day 8, the site is no longer hot or warm, but there?s still a round 3-inch red mark covering the injection area. Forgive my language, but this is a bitch of a vaccine
VEINS POPPED UP IN BOTH FEET LOOKS LIKE VARICOSE VEINS; NODULES IN HANDS AND FEET; HARD AT INJECTION SITE; FEET TURNED RED-PINK COLOR FROM FEET TO CALVES; TIRED; INJECTION SITE SWELLING; HEADACHE; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, and other pre-existing medical conditions included the patient's blood group was o- type. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAY-2021, the subject experienced veins popped up in both feet looks like varicose veins. On 07-MAY-2021, the subject experienced nodules in hands and feet. On 07-MAY-2021, the subject experienced hard at injection site. On 07-MAY-2021, the subject experienced feet turned red-pink color from feet to calves. On 07-MAY-2021, the subject experienced tired. On 07-MAY-2021, the subject experienced injection site swelling. On 07-MAY-2021, the subject experienced headache. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine  was not applicable. The patient recovered from nodules in hands and feet on MAY-2021, hard at injection site, and feet turned red-pink color from feet to calves on 07-MAY-2021, and headache on 08-MAY-2021, was recovering from tired, and injection site swelling, and had not recovered from veins popped up in both feet looks like varicose veins. This report was non-serious.
This spontaneous report was received from a medical assistant concerning a 12-year-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-APR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot number: L026602, expiration date: 17-OCT-2017, dose, dose number, anatomical location and route of administration were not provided). The vaccine underwent temperature excursion of either +1 or -1 degree Celsius for 255.5 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as all the data was already obtained.
Hyperglycemia due to diabetes mellitus; Left-sided muscle weakness; Left-sided weakness; Stroke
Heart palpitations.   I received my vaccine at 2:30pm and going to bed that night I felt as if my heart was fluttering and skipping beats. My arm was also extremely sore.   The heart palpitations subsided by the next morning but I?m now hesitant to receive my second dose and afraid that it?ll cause a more serious heart issue.
Cellulitis Rt arm red and hot to touch 8/19/12 ROCEPHIN 1000 mg given. Will start taking oral Cephalexin 500mg Bid x 10 days.
unable to walk; Difficulty with speech; Pain in left arm; Injection site red and swollen; Injection site red and swollen; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (unable to walk), SPEECH DISORDER (Difficulty with speech), INJECTION SITE PAIN (Pain in left arm), INJECTION SITE ERYTHEMA (Injection site red and swollen) and INJECTION SITE SWELLING (Injection site red and swollen) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain in left arm), INJECTION SITE ERYTHEMA (Injection site red and swollen) and INJECTION SITE SWELLING (Injection site red and swollen). On 26-Feb-2021, the patient experienced GAIT INABILITY (unable to walk) and SPEECH DISORDER (Difficulty with speech). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, GAIT INABILITY (unable to walk), SPEECH DISORDER (Difficulty with speech), INJECTION SITE PAIN (Pain in left arm), INJECTION SITE ERYTHEMA (Injection site red and swollen) and INJECTION SITE SWELLING (Injection site red and swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Aug-2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: Follow up received and events added.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 16-OCT-2014, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp 06-NOV-2016) (dose and site not reported). On and unspecified dates, the GARDASIL vaccine had a temperature excursion: 48 hours. The highest recorded temperature was 47 (8.333333333 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
No adverse effect reported; 2 doses of improperly stored pneumovax was administered to unknown patients; This spontaneous non-valid report was received from a registered nurse concerning a unspecified number of patients.  The patients concurrent conditions, medical history, drug reactions or allergies were not reported. Concomitant medications included sterile diluent.  On 17-APR-2019, the patients received 1 doses of improperly stored Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) administered intramuscularly (lot#: R031812, expiration date 26-SEP-2020) and on an unknown date, the patients received 1 dose of improperly stored Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) administered intramuscularly (lot #: S002639, expiration date: 26-SEP-2020). The time frame was 17 minutes and the temperature was 0.3 degrees Celsius. The call was due to a data logger. There was previous temperature excursions. No adverse effects were reported.  This report is considered to be non-valid due to a lack of patients identifiers.
felt bad/not feeling that good; aching; head is hurting a little bit; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad/not feeling that good), MYALGIA (aching) and HEADACHE (head is hurting a little bit) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FEELING ABNORMAL (felt bad/not feeling that good), MYALGIA (aching) and HEADACHE (head is hurting a little bit). At the time of the report, FEELING ABNORMAL (felt bad/not feeling that good) was resolving and MYALGIA (aching) and HEADACHE (head is hurting a little bit) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Swelling in right arm, redness and itchiness. Came in less then 24 hrs after vaccine administered.
myocarditis, woke up with fatigue, elevated heart rate, chest tightness, faintness. Smart watch says ECG is normal but my heart rate is about 30bpm higher than normal
RECIEVED  VACCINE ON FRIDAY, 08-06-2022, ON MONDAY, 08-08- 2022 STATRTED HAVING COVID SYMPYOMS, TESTED POSITIVE TH E FOLLOWING  DAY.   LAST TESTED POSSITIVE ON 08-21- 2022.  FELT LIKE A COLD.  ITCHY THROAT, COUGHING UP MUCOUS AND DIZZINESS.   SYMPTONS  ARE STLL PRESENT.
This spontaneous report as received from a physician refers to a male patient of unknown age. The patient was vaccinated with GARDASIL in August 2012, "in the past 8 days". Lot#, route and specified date were not reported. It was reported that the patient experienced syncope and vomiting with in 5 minutes of receiving GARDASIL. The outcome of syncope and vomiting was unknown. The patient sought medical attention for the adverse event occurred in the physician's office. This is one of several reports received from the same source. (1209USA002964, 1209USA003021, 1209USA003022, 1209USA003023, 1209USA00166). Additional information has been requested.
After second dose: Fever 101.2 degrees Days 1-2  Fever 99.8 degrees after Tylenol 500mg Grogginess, dizziness, brain fatigue Day 1 02/20 to now 04/03, over one month
This spontaneous prospective pregnancy report as received from a nurse refers to a 17 year old female patient. The patient had no pertinent medical history or no known drug reactions/allergies. On 30-MAY-2014 the patient was vaccinated with her third dose of GARDASIL (lot # J012212, expiration date 18-FEB-2016, dose 0.5 ml, intramuscularly in the right deltoid ). No concomitant medications were provided. The patient had ultrasound on 24-JUL-2014 and it was found that client was 30 weeks and 3 days pregnant. Blood work and other lab tests were completed and the results were unspecified. The nurse stated the patient was not experiencing any adverse effects. The Last Menstrual Period (LMP) was estimated on 23-DEC-2013 (also reported on 03-APR-2014). The Estimated date of delivery (EDD) was estimated on 29-SEP-2014. No treatment was given. The patient did not seek medical attention. The outcome of the pregnancy was unknown. Additional information has been requested.
arm heavy & sore-hot-red burning w/large knot, diarrhea, h/a;
Makes me sick; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 05-Dec-2020.  This case involves a patient of unknown demographics who reported that Influenza Vaccine made him/her sick (Illness).  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the reporter stated that Influenza Vaccine made him/her sick (Illness)).  Action taken was not applicable.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  There will be no information about the batch number in this case.  The reporter assessed the causal relationship with suspect vaccine as related.
Redness around left eyeball; Feel heaviness when I blink; Little pain; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old (non-pregnant) female patient received BNT162b2 (pfizer-biontech covid-19 mRNA vaccine; Lot Number: EW0168) dose 1 single via an unspecified route of administration in the arm left on 14May2021 at 18:00 ( age at vaccination 25-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any concomitant medications. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included COVID-19 positive. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced redness around left eyeball, feel heaviness when patient blink and little pain. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test included covid 19 was positive on an unknown date.Therapeutic measures were not taken as a result of these events. The clinical outcome of all the events was not recovered at the time of this report.  Follow-up attempts are completed. No further information is expected.
Nausea, diarrhea, bursitis in right knee increasing in pain after each administration of the vaccine. Ice, Aleve, rest.
Both second dose (6 months prior) and this reported booster shot had similar effects:  extreme chills and tiredness that started approximately 17 hours after vaccines.
Shortness of breath EMS on scene and treated the client. *Epi given @ scene by EMS.
Client states arm was red from injection site to elbow, edema, sore, itchy first day, denies any fever or chills.
vision was off; seeing black shapes, lines, specks floating in the air; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (vision was off) and VISUAL IMPAIRMENT (seeing black shapes, lines, specks floating in the air) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B2-A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced VISION BLURRED (vision was off) and VISUAL IMPAIRMENT (seeing black shapes, lines, specks floating in the air). On 29-Mar-2021, VISION BLURRED (vision was off) and VISUAL IMPAIRMENT (seeing black shapes, lines, specks floating in the air) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Moderate pain at site of injection, low-grade fever several hours after injection, 100.2°, moderate sharp pain in left leg.
Per notes from medical provider: ?HPI Patient comes in for evaluation of rash. Onset of rash 315. Had just received immunizations including COVID booster, yellow fever, typhoid and flu vaccine 215. Rash is itchy and red. Rash is generalized and spread to his chest back arms neck abdomen and legs. Rash is itchy. States his throat feels irritated and scratchy. States he did have nausea but that is better. Denies chest pain or airway closure. States he did take some ibuprofen. He denies body aches, headache, syncope. Denies history of allergic reactions to vaccines in the past. Mother accompanies patient here in the clinic. Allergic Reaction This is a new problem. The current episode started today. The problem occurs daily. The problem has been rapidly worsening since onset. Associated symptoms include coughing (dry) and a rash. Pertinent negatives include no abdominal pain, chest pain, eye itching, eye redness, stridor, trouble swallowing, vomiting or wheezing. There is no history of food allergies. Encounter Diagnoses  -T80.69XA Allergic reaction to vaccine -L50.9 Hives -L29.9 Pruritus Patient was seen today for allergic reaction. Diagnoses and all orders for this visit: Allergic reaction to vaccine - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Educated mother she can give another Benadryl 25 mg if needed. Educational handout given on medications. Educated on EpiPen. If airway closure did educate on administration of EpiPen and to go to the ER immediately or call 911. Mother in agreement with plan and verbalized understanding. Hives - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Pruritus - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min?
I began throwing up every day and having diarrhea I had intense joint pain, weakness in legs, fatigue, shortness of breath, chest pain. completely lost ability to work out due to fatigue and muscle weakness and pain.  I was tested for rheumatoid arthritis in March 20221 I had a severe rash in september 2021 without any changes to anything.  I had severe night sweats for up to 3 months after.  I started having hot flashes around the 6 month time frame around the time my husband was vaccinated with modern vaccine.  I have had issues with my menstrual cycle.  I am still having symptoms still with joint pain, muscle weakness, fatigue, and vomiting most days
Pt presents with redness, swelling, warmth, and severe pain of vaccine site.  The sit is noted to be on the medial upper arm, 3 cm above the elbow joint.  Area of erythema measures  3 cm x 4cm.